S. J. Roffey

949 total citations
12 papers, 715 citations indexed

About

S. J. Roffey is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, S. J. Roffey has authored 12 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in S. J. Roffey's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). S. J. Roffey is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). S. J. Roffey collaborates with scholars based in United Kingdom, United States and France. S. J. Roffey's co-authors include Dennis A. Smith, Peter F. Troke, Irja Lutsar, R. Scott Obach, Pierre Comby, Angus N. R. Nedderman, Don K. Walker, S. G. Jezequel, Nolan Wood and Soren Cole and has published in prestigious journals such as Clinical Infectious Diseases, Food and Chemical Toxicology and Drug Metabolism and Disposition.

In The Last Decade

S. J. Roffey

12 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. J. Roffey United Kingdom 8 412 269 125 124 121 12 715
Konrad E. Tomaszewski United States 11 342 0.8× 216 0.8× 90 0.7× 108 0.9× 225 1.9× 18 753
Pierre Comby France 9 292 0.7× 119 0.4× 75 0.6× 87 0.7× 69 0.6× 12 525
S. G. Jezequel United Kingdom 8 244 0.6× 126 0.5× 112 0.9× 108 0.9× 150 1.2× 12 596
F A deLuna United States 15 218 0.5× 108 0.4× 166 1.3× 130 1.0× 164 1.4× 24 844
Satoshi Kishino Japan 16 232 0.6× 176 0.7× 108 0.9× 127 1.0× 197 1.6× 56 711
R A Yeates Germany 16 251 0.6× 182 0.7× 125 1.0× 85 0.7× 82 0.7× 35 692
Rachel Courtney United States 14 802 1.9× 661 2.5× 85 0.7× 232 1.9× 314 2.6× 18 1.7k
Tawfique K. Daneshmend United Kingdom 10 177 0.4× 176 0.7× 130 1.0× 71 0.6× 69 0.6× 14 544
Josephine Lim China 14 850 2.1× 717 2.7× 110 0.9× 296 2.4× 96 0.8× 24 1.3k
Marieke G. G. Sturkenboom Netherlands 20 610 1.5× 511 1.9× 68 0.5× 362 2.9× 115 1.0× 49 1.1k

Countries citing papers authored by S. J. Roffey

Since Specialization
Citations

This map shows the geographic impact of S. J. Roffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. Roffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. Roffey more than expected).

Fields of papers citing papers by S. J. Roffey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. J. Roffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. Roffey. The network helps show where S. J. Roffey may publish in the future.

Co-authorship network of co-authors of S. J. Roffey

This figure shows the co-authorship network connecting the top 25 collaborators of S. J. Roffey. A scholar is included among the top collaborators of S. J. Roffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. Roffey. S. J. Roffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Nedderman, Angus N. R., et al.. (2006). Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: A rationale for long-lived plasma radioactivity. Xenobiotica. 36(5). 399–418. 13 indexed citations
3.
Harris, Simon R., et al.. (2004). A sensitive HPLC-MS-MS assay for quantitative determination of midazolam in dog plasma. Journal of Pharmaceutical and Biomedical Analysis. 35(1). 127–134. 6 indexed citations
5.
Roffey, S. J., Soren Cole, Pierre Comby, et al.. (2003). THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN. Drug Metabolism and Disposition. 31(6). 731–741. 258 indexed citations
6.
Lutsar, Irja, S. J. Roffey, & Peter F. Troke. (2003). Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised Patients. Clinical Infectious Diseases. 37(5). 728–732. 196 indexed citations
7.
Webster, Robert O., et al.. (2003). Pharmacokinetics and disposition of a novel NMDA glycine site antagonist (UK-240,455) in rats, dogs and man. Xenobiotica. 33(5). 541–560. 5 indexed citations
8.
Walker, Don K., et al.. (2001). Pharmacokinetics and metabolism of a selective PDE5 inhibitor (UK-343,664) in rat and dog. Xenobiotica. 31(8-9). 651–664. 8 indexed citations
10.
Venn, Richard F., et al.. (2000). Fluorescence determination of sulphobutylether-β-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation. Journal of Pharmaceutical and Biomedical Analysis. 22(5). 773–780. 16 indexed citations
11.
Reichel, Andreas, et al.. (1998). The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier.. PubMed. 36(2). 84–6. 3 indexed citations
12.
Roffey, S. J., Rheeda L. Walker, & G. Gordon Gibson. (1990). Hepatic peroxisomal and microsomal enzyme induction by citral and linalool in rats. Food and Chemical Toxicology. 28(6). 403–408. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026